Developing therapies to cure neurodegeneration and cancer by harnessing the immune system.
Acutus Medical has pioneered an advanced intracardiac mapping system, featuring dynamic arrhythmia visualization, to improve the treatment of atrial arrhythmias.
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
Gracell is developing cell and gene therapies that deliver fast, deep and durable responses for cancer patients.
TytoCare is transforming primary care by putting health in the hands of consumers.
From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.
We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 100 distinguished scientific, medical, investment and other professionals manages over $17 billion across public and private company investments worldwide.
Health noun \`helth also `heltth\
- The condition of being sound in body, mind, or spirit; freedom from physical disease or pain
- The central purpose of OrbiMed's global quest to discover and finance the most promising life sciences innovations
Exciting healthcare breakthroughs are occurring worldwide, so our team is working 24/7 around the globe to find them
Shanghai Office Tower
268 Xizang Middle Road
Shanghai 200001, P.R. China
+ (86) 21-6335-1700
1 Austin Road West, Unit 01
Kowloon, Hong Kong
For general inquiries please contact us at +1 (212) 739-6400.